Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.
D000328:Adult; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D004048:Diethylamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D007475:Ion Exchange Resins / Q000009:adverse effects / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D003911:Dextrans; D004048:Diethylamines; D007475:Ion Exchange Resins; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002994:Clofibrate